Company intelligence / Profile preview

Brava

Boulder, Colorado, United Statesshop.brava.com ↗

Ownership: Private
Employees: ~4
Development stage: Commercial

Overview

Brava Diagnostics developed rapid point-of-care diagnostic tests using the LightDeck optical system. The company focused on unmet needs in acute care settings and pivoted during the COVID‑19 pandemic to develop a multiplex antibody panel. In August 2020, Brava merged with MBio to accelerate commercialization efforts. The combined team rapidly advanced their COVID‑19 test toward FDA EUA submission.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: DeviceDiagnostic test
Industry: Protein Biomarker Diagnostics

Partnerships

Licensed technology from MBio prior to merger; no major pharma partnerships disclosed pre-merger.

Beyond the preview

Go deeper on Brava.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brava.

Explore the full profile